Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance CentreA Cross-Sectional Period-Prevalence Study

被引：0
|
作者：
Betsabé Sánchez-Sánchez
Marina Altagracia-Martínez
Jaime Kravzov-Jinich
Consuelo Moreno-Bonett
Everardo Vázquez-Moreno
Juan Manuel Martínez-Núñez
机构：
[1] Metropolitan Autonomous University-Xochimilco,Division of Biological and Health Sciences, Department of Biological Systems
[2] Pfizer Laboratory,undefined
来源：
Drug Safety | 2012年 / 35卷
关键词：
Adverse Drug Reaction; Pharmaceutical Industry; Pregabalin; Adverse Drug Reaction Report; Anatomical Therapeutic Chemical Classification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The Mexican National Centre of Pharmacovigilance (CNFV) receives suspected adverse drug reaction (ADR) reports from the pharmaceutical industry, Federal States Centre of Pharmacovigilance (CEFV) and Healthcare Institution Centres of Pharmacovigilance (CIFV). The completeness of these suspected ADR reports is particularly important for the proper evaluation of drug safety.
引用
收藏
页码：837 / 844
页数：7
相关论文
共 50 条
  • [21] Rates of Spontaneous Reports of Adverse Drug Reactions for Drugs Reported in Children A Cross-Sectional Study with Data from the Swedish Adverse Drug Reaction Database and the Swedish Prescribed Drug Register
    Wallerstedt, Susanna M.
    Brunlof, Gertrud
    Sundstrom, Anders
    DRUG SAFETY, 2011, 34 (08) : 669 - 682
  • [22] Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
    A. C. B. van Orten-Luiten
    A. Janse
    R. A. M. Dhonukshe-Rutten
    R. F. Witkamp
    European Journal of Clinical Pharmacology, 2016, 72 : 605 - 614
  • [23] Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
    van Orten-Luiten, A. C. B.
    Janse, A.
    Dhonukshe-Rutten, R. A. M.
    Witkamp, R. F.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (05) : 605 - 614
  • [24] Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study
    Nisa, Zaka Un
    Zafar, Ayesha
    Zafar, Fatima
    Pezaro, Sally
    Sher, Farooq
    CURRENT DRUG SAFETY, 2020, 15 (02) : 137 - 146
  • [25] Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study
    Zhang, Xuemei
    Niu, Rui
    Feng, Bianling
    Guo, Jiadong
    Liu, Ying
    Liu, Xinyu
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (01) : 59 - 68
  • [26] Dug-drug Interactions as a Public Health Problem: Retrospective Study of Adverse Drug Reaction Reports from the National Portuguese Pharmacovigilance System
    Gouveia, Maria
    Fernandes, Joao
    Queiroz, Sandra
    Silva, Marcia
    DRUG SAFETY, 2024, 47 (12) : 1324 - 1325
  • [27] Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study
    Insani, Widya N.
    Whittlesea, Cate
    Wei, Li
    PLOS ONE, 2024, 19 (07):
  • [28] Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study
    Angamo, Mulugeta Tarekegn
    Curtain, Colin Michael
    Chalmers, Leanne
    Yilma, Daniel
    Bereznicki, Luke
    PLOS ONE, 2017, 12 (10):
  • [29] Adverse Drug Reactions in Patients with Alzheimer's Disease or Another Dementia in France: A National Cross-Sectional Study
    Laroche, Marie-Laure
    Perault-Pochat, Marie-Christine
    Ingrand, Isabelle
    Merle, Louis
    Kreft-Jais, Carmen
    Castot, Anne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 86 - 87
  • [30] Knowledge, attitude and practice towards pharmacovigilance and reporting of adverse drug reactions among health care professionals in Albania: A cross-sectional study
    Shkreli, Rezarta
    Dhamo, Klodiola
    Haloci, Entela
    Tabaku, Afrim
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (03) : 713 - 721
12345